Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Novel therapies for memory cells in autoimmune diseases.
The two faces of neuromyelitis optica.
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration.
Integrated analysis of daclizumab HYP pharmacokinetics from three phase 1 studies
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Multiple sclerosis: an immune or neurodegenerative disorder?
Imaging outcomes for trials of remyelination in multiple sclerosis.
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
Patient reported outcome measures in neurogenic bladder.
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.
New approaches in the management of multiple sclerosis.
GEMSP: A New Therapeutic Approach to Multiple Sclerosis.
Receptos announces issuance of composition of matter patents covering proprietary lead product candidate RPC1063
Differential roles of microglia and monocytes in the inflamed central nervous system.
Prospective memory, emotional valence, and multiple sclerosis.
Treatment of neuromyelitis optica.
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.

Pages